Latest Breaking News On - மனம் மருந்து ஆஸ்திரேலியா - Page 1 : comparemela.com

Emyria appoints principal investigator to lead MDMA trial for Post-Traumatic Stress Disorder The company believes the new principal investigators’ clinical experience in psychedelic-assisted therapies will help develop its evidence-based and scalable clinical services for patients with major mental health concerns. MDMA-assisted therapy has shown promise for treating Post Traumatic Stress Disorder patients. Emyria Limited (ASX:EMD) has appointed consultant psychiatrist Dr Eli Kotler as principal investigator for its upcoming clinical trial on MDMA-assisted psychotherapy for treatment-resistant Post Traumatic Stress Disorder (PTSD), known as EMDMA-001. The appointment complement’s Emyria’s growing team of consultant psychiatrist advisors such as retired naval veteran and consultant psychiatrist, Dr Richard Magtengaard.

Richard magtengaardEli kotlerMichael winloEmyria limitedPost traumatic stress disorderMind medicinePrincipal investigatorMind medicine australiaபோஸ்ட் அதிர்ச்சிகரமான மன அழுத்தம் கோளாறுமனம் மருந்துப்ரிந்ஸிபல் புலனாய்வாளர்மனம் மருந்து ஆஸ்திரேலியா